Association between an interleukin-13 promoter polymorphism and atopy

Eur J Immunogenet. 2003 Oct;30(5):355-9. doi: 10.1046/j.1365-2370.2003.00416.x.

Abstract

Several studies indicate genetic involvement of Th2 cytokines in allergic diseases. Interleukin (IL)-13 has been mapped to the cytokine cluster on chromosome 5q31-33, which has been associated with atopic conditions. Recently, an association was reported between the T allele in a promoter polymorphism in the IL-13 gene (C to T exchange) at position -1055 and allergic asthma in a population study in the Netherlands. This observation was apparently confirmed in a case-control study using probands and spouses from a Dutch asthma family study, but the polymorphism in that study was reported to occur at position -1111. In the present study, we established that this polymorphism is located at position -1024 relative to the ATG translation initiation codon, and investigated whether it confers a genetic predisposition to atopic conditions and the Th1 condition multiple sclerosis (MS) in Caucasian subjects. We confirmed the association between the IL-13 -1024TT genoype and inhalation allergy (P = 2.4E-02). By combining the data from the three studies, we demonstrated a strong association (P = 1.09E-05) between the IL-13 -1024 marker and inhalation allergy. Furthermore, we showed for the first time that this association also exists in atopic dermatitis (P = 2.0E-02). No association with MS was found.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Base Sequence
  • Genetic Predisposition to Disease
  • Humans
  • Hypersensitivity, Immediate / genetics*
  • Immunoglobulin E / immunology
  • Interleukin-13 / genetics*
  • Molecular Sequence Data
  • Multiple Sclerosis / genetics*
  • Polymerase Chain Reaction
  • Polymorphism, Genetic*
  • Promoter Regions, Genetic*
  • Th1 Cells / immunology
  • Th2 Cells / immunology

Substances

  • Interleukin-13
  • Immunoglobulin E